Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

New oncogene target for breast cancer: LMTK3

Prof Justin Stebbing - Imperial College London, UK
New oncogene target for breast cancer: LMTK3 ( Prof Justin Stebbing - Imperial College London, UK )
22 Jun 2011

ASCO 2011: Key head and neck cancer research

Prof Jacques Bernier - Clinique de Genolier, Genolier, Switzerland
ASCO 2011: Key head and neck cancer research ( Prof Jacques Bernier - Clinique de Genolier, Genolier, Switzerland )
22 Jun 2011

Importance of geriatric oncology

Prof Hyman Muss - University of North Carolina Medical School, USA
Importance of geriatric oncology ( Prof Hyman Muss - University of North Carolina Medical School, USA )
22 Jun 2011

Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma

Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011

PTEN expression does not diminish trastuzumab effectiveness

Prof Edith Perez - Mayo Clinic, Florida, USA
PTEN expression does not diminish trastuzumab effectiveness ( Prof Edith Perez - Mayo Clinic, Florida, USA )
20 Jun 2011

Advances in breast cancer research from ASCO 2011

Dr David Miles - Mount Vernon Hospital, London, UK
Advances in breast cancer research from ASCO 2011 ( Dr David Miles - Mount Vernon Hospital, London, UK )
20 Jun 2011

The ENERGY trial

Prof Cheryl Rock - University of California, USA
The ENERGY trial ( Prof Cheryl Rock - University of California, USA )
20 Jun 2011

Cancer prevention through education

Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
Cancer prevention through education ( Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy )
17 Jun 2011

Translational research from the Vall d'Hebron Institute of Oncology

Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Translational research from the Vall d'Hebron Institute of Oncology ( Prof Joan Seoane - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011

Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer

Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain
Vall d´Hebron Institute of Oncology; advancing personalized and targeted therapies against cancer ( Prof José Baselga - Massachusetts General Hospital, Boston, USA; Prof Josep Tabernero, Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Jun 2011

Ethics of early-phase clinical trials

Dr Steven Joffe – Dana-Farber Cancer Institute, Boston, USA
Ethics of early-phase clinical trials ( Dr Steven Joffe – Dana-Farber Cancer Institute, Boston, USA )
17 Jun 2011

Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

Dr Gunnar Kristensen - Norwegian Radium Hospital, Oslo, Norway
Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence ( Dr Gunnar Kristensen - Norwegian Radium Hospital, Oslo, Norway )
17 Jun 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation